Sonovascular

• ·Sonovascular’s last known valuation is $35.7M (Feb 2026).
• ·It has raised $11.2M across 1 recorded rounds; the latest was Later Stage VC ($6.0M) in Feb 2026.
• ·Notable investors include Band of Angels, Innovation Partnerships, ShangBay Capital, Carolina Research Ventures, Harbright Ventures — 9 tracked in total.
• ·2 investment vehicles were formed to buy Sonovascular shares in the last 12 months, reporting $264K sold to 13 investors, per SEC Form D filings.
• ·Sonovascular has filed 2 Form Ds with the SEC since 2022, most recently Jan 2023 ($2.2M sold to 26 investors).
• ·Status: Privately Held (backing).

In the last 12 months, 2 investment vehicles were formed to buy Sonovascular shares, reporting $264K sold to 13 investors across 3 sponsors. Most recent filing Dec 2025. Vehicles like these are how secondary buyers pool demand for a name; a rising count is a demand signal.

Developer of an ultrasound-assisted thrombectomy platform designed to support clot removal during interventional procedures. The company offers an ultrasound-based system using microbubble-mediated cavitation and thrombolytic enhancement, enabling interventional clinicians to perform single-session catheter-based clot treatment with controlled mechanical action.

Sector

Healthcare

HQ

Chapel Hill, NC, United States

Founded

2017

Employees

9

Website

sonovascular.com/

Ownership

Privately Held (backing)